Abstract
Two cis-diamminedichloroplatinum (II) (cisplatin)-inducible proteins [b 130 (approximately 130 kDa) and b95 (approximately 95 kDa]) in HeLa cells that recognize both the cisplatin-modified and u.v.-modified DNA were identified in this study. These damage-recognition proteins were overexpressed in cisplatin-resistant HeLa cells. The results suggest that the damage-recognition proteins are regulated in the cells in response to DNA damage, and they may be important for DNA repair and probably the emergence of cisplatin resistance.
Full text
PDF![875](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8142/1151325/bed52a8831a8/biochemj00154-0284.png)
![876](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8142/1151325/7bf3c3d0ed15/biochemj00154-0285.png)
![877](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8142/1151325/1c6c0810355b/biochemj00154-0286.png)
![878](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8142/1151325/673908d314e3/biochemj00154-0287.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bird P., Gething M. J., Sambrook J. Translocation in yeast and mammalian cells: not all signal sequences are functionally equivalent. J Cell Biol. 1987 Dec;105(6 Pt 2):2905–2914. doi: 10.1083/jcb.105.6.2905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- Carthew R. W., Chodosh L. A., Sharp P. A. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell. 1985 Dec;43(2 Pt 1):439–448. doi: 10.1016/0092-8674(85)90174-6. [DOI] [PubMed] [Google Scholar]
- Chao C. C., Huang S. L., Huang H. M., Lin-Chao S. Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA. Mol Cell Biol. 1991 Apr;11(4):2075–2080. doi: 10.1128/mcb.11.4.2075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chao C. C., Lee Y. L., Cheng P. W., Lin-Chao S. Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II). Cancer Res. 1991 Jan 15;51(2):601–605. [PubMed] [Google Scholar]
- Chao C. C., Rosenstein B. S. Induction of sister-chromatid exchanges in ICR 2A frog cells exposed to 254 nm and solar UV wavelengths. Photochem Photobiol. 1985 May;41(5):625–627. doi: 10.1111/j.1751-1097.1985.tb03537.x. [DOI] [PubMed] [Google Scholar]
- Chu G., Chang E. Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc Natl Acad Sci U S A. 1990 May;87(9):3324–3327. doi: 10.1073/pnas.87.9.3324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chu G., Chang E. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science. 1988 Oct 28;242(4878):564–567. doi: 10.1126/science.3175673. [DOI] [PubMed] [Google Scholar]
- Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donahue B. A., Augot M., Bellon S. F., Treiber D. K., Toney J. H., Lippard S. J., Essigmann J. M. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin. Biochemistry. 1990 Jun 19;29(24):5872–5880. doi: 10.1021/bi00476a032. [DOI] [PubMed] [Google Scholar]
- Glazer P. M., Greggio N. A., Metherall J. E., Summers W. C. UV-induced DNA-binding proteins in human cells. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1163–1167. doi: 10.1073/pnas.86.4.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hennighausen L., Lubon H. Interaction of protein with DNA in vitro. Methods Enzymol. 1987;152:721–735. doi: 10.1016/0076-6879(87)52076-6. [DOI] [PubMed] [Google Scholar]
- Hirschfeld S., Levine A. S., Ozato K., Protić M. A constitutive damage-specific DNA-binding protein is synthesized at higher levels in UV-irradiated primate cells. Mol Cell Biol. 1990 May;10(5):2041–2048. doi: 10.1128/mcb.10.5.2041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hospers G. A., Mulder N. H., De Vries E. G. Mechanisms of cellular resistance to cisplatin. Med Oncol Tumor Pharmacother. 1988;5(3):145–151. doi: 10.1007/BF02986437. [DOI] [PubMed] [Google Scholar]
- Loehrer P. J., Einhorn L. H. Drugs five years later. Cisplatin. Ann Intern Med. 1984 May;100(5):704–713. doi: 10.7326/0003-4819-100-5-704. [DOI] [PubMed] [Google Scholar]
- Miskimins W. K., Roberts M. P., McClelland A., Ruddle F. H. Use of a protein-blotting procedure and a specific DNA probe to identify nuclear proteins that recognize the promoter region of the transferrin receptor gene. Proc Natl Acad Sci U S A. 1985 Oct;82(20):6741–6744. doi: 10.1073/pnas.82.20.6741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
- Okayama H., Berg P. High-efficiency cloning of full-length cDNA. Mol Cell Biol. 1982 Feb;2(2):161–170. doi: 10.1128/mcb.2.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenberg B. Fundamental studies with cisplatin. Cancer. 1985 May 15;55(10):2303–23l6. doi: 10.1002/1097-0142(19850515)55:10<2303::aid-cncr2820551002>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Ushay H. M., Tullius T. D., Lippard S. J. Inhibition of the BamHI cleavage and unwinding of pBR322 deoxyribonucleic acid by the antitumor drug cis-dichlorodiammineplatinum(II). Biochemistry. 1981 Jun 23;20(13):3744–3748. doi: 10.1021/bi00516a012. [DOI] [PubMed] [Google Scholar]